4//SEC Filing
Smith Stan 4
Accession 0001878313-25-000045
CIK 0001878313other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 4:43 PM ET
Size
7.1 KB
Accession
0001878313-25-000045
Insider Transaction Report
Form 4
Smith Stan
Director
Transactions
- Purchase
Common Stock
2025-11-24$0.99/sh+10,000$9,900→ 1,334,289 total(indirect: See Footnote) - Purchase
Common Stock
2025-11-25$0.98/sh+15,000$14,700→ 1,349,289 total(indirect: See Footnote)
Footnotes (3)
- [F1]The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.9675 to $0.9899, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
- [F2]These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
- [F3]The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.9550 to $1.05, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001913199
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 4:43 PM ET
- Size
- 7.1 KB